BAT progresses COVID-19 candidate vaccine into Phase I human clinical trials

(R&D at British American Tobacco) BAT's US Bio-tech arm, Kentucky BioProcessing (KBP) today announced plans to commence a Phase I first-time-in-human study of its COVID-19 vaccine candidate following approval of its Investigational New Drug application by the US Food and Drug Administration (FDA). Enrolment for the study is expected to begin shortly.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news